Georgia Urology, the largest urology practice in Georgia, announced that Dr. Brent Sharpe has been designated as Georgia’s first and only Center of Excellence for Rezūm™ Water Vapor Therapy treatment – a minimally invasive in-office procedure for men looking to treat their enlarged prostate (also known as benign prostatic hyperplasia or BPH), not just the symptoms. Rezūm™ Therapy uses natural water vapor to reduce the size of the prostate and provide lasting symptoms relief from BPH without invasive surgery or some of the potential side effects of prescription drugs.
“This recognition shows the practice’s commitment to providing world-class care to our patients,” says Dr. Sharpe. “Our aim is to always provide effective options, and Rezūm™ helps us do just that for men who are looking for BPH relief.”
Additionally, Dr. Sharpe is the only urologist in Georgia designated as a Rezūm™ Center of Excellence and a UroLift® Center of Excellence, both minimally invasive BPH therapies. These designations recognize that Dr. Sharpe has achieved a high level of training and experience with the UroLift® System and Rezūm™ Water Vapor Therapy. Dr. Sharpe’s accolades demonstrate his commitment to providing exemplary care to men with BPH.
To consult with a urologist at Georgia Urology about BPH visit GaUrology.com to schedule an appointment.
Drs. John Abbott, Roosevelt Allen, Ronald Anglade, Emily Blum, Daniel Canter, Carl Capelouto, Wolfgang Cerwinka, Bert Chen, Shuvro De, Walter Falconer, Michael Garcia-Roig, Froylan Gonzalez, Mark Haber, Andrew Kirsch, Lewis Kriteman, Lambda Msezane, Warren Todd Oberle, Joel Rosenfeld, Hal Scherz, Edwin Smith, Shaya Taghechian, Jerry Yuan, and Barry Zisholtz appear in Atlanta magazine’s July issue […]
On Friday June 15th, Dr. Ronald Anglade of Georgia Urology appeared on The Shelley Wynter Show on 106.7 FM radio. During the segment, Dr. Anglade and host Shelley Wynter discussed a variety of topics including bladder conditions, PSA levels, and biopsies. Dr. Anglade also discussed treatment options for benign prostate hyperplasia and the symptoms of […]
Advances in minimally invasive cancer treatments are reshaping what’s possible for patients with low and intermediate-grade prostate cancer. One of the most promising breakthroughs is the NanoKnife system, which utilizes irreversible electroporation (IRE) — controlled electrical pulses — to destroy cancer cells while preserving blood vessels, nerves, and the continence mechanism or the muscle that maintains […]
